Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study.
Marco SebastianiVincenzo VeneritoElenia LaurinoStefano GentileschiFabiola AtzeniClaudia CanofariDario AndrisaniGiulia CassoneMarlea LavistaFrancesco D'AlessandroCaterina VacchiArnaldo ScardapaneBruno FredianiMassimiliano CazzatoCarlo SalvaraniFlorenzo IannoneAndreina ManfrediPublished in: Journal of clinical medicine (2023)
We observed that more than a third of RA-ILD patients showed a fibrosing progressive pattern and might benefit from antifibrotic treatment. This study shows some limitations, such as the retrospective design. The exclusion of respiratory symptoms' evaluation might underestimate the prevalence of progressive lung disease but increases the value of results.
Keyphrases
- interstitial lung disease
- rheumatoid arthritis
- systemic sclerosis
- multiple sclerosis
- idiopathic pulmonary fibrosis
- end stage renal disease
- disease activity
- newly diagnosed
- clinical trial
- randomized controlled trial
- chronic kidney disease
- ankylosing spondylitis
- peritoneal dialysis
- depressive symptoms
- patient reported outcomes
- replacement therapy